May 29, 2024 · Form 4 insider transaction
Bozic Carmen sold 2,280 shares of Vertex Pharmaceuticals Incorporated at $445.56 per share, a transaction worth $1.02M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024.